WuXi’s manufacturing subsidiary, Syn-The-All Pharmaceutical Co., Ltd (STA), has begun operation of a high-potency active pharmaceutical ingredient (HPAPI) laboratory in Shanghai.   The lab will support process development and clinical-trial supply of high-potency small-molecule products at kilogram scale.  With an increasing use of HPAPIs in drug discovery and development, this new service augments WuXi’s ability to provide highly efficient and cost-effective solutions for our partners worldwide.


Related links:

See official press release here.
WuXi’s Analytical and Stability Testing Facilities Pass FDA Audit
WuXi Manufacturing Facility Passes FDA Inspection